Where Will Moderna Stock Be in 5 Years?
The Motley Fool
MARCH 3, 2024
Moderna (NASDAQ: MRNA) was a top stock to own during the early stages of the pandemic. The COVID-19 vaccine maker reached a market cap of nearly $200 billion at its peak in 2021. But nowadays, with revenue from its vaccine diminishing and no longer being a strong growth catalyst, investors have become bearish on the healthcare stock. Since 2022, shares of Moderna have fallen by more than 60%.
Let's personalize your content